基本信息: 期刊简称:Rheumatology Advances In Practice 是否OA:开放 是否预警:否 Gold OA文章占比:93.30% 出版信息: 出版地区:United Kingdom 出版语言:English 出版商:Oxford University Press 评价信息: JCR分区:Q3 影响因子:2.1 CiteScore:3.6 投稿咨询 加急咨询 ...
《风湿病学实践进展》(Rheumatology Advances In Practice)是一本以Medicine-Rheumatology综合研究为特色的国际期刊。该刊由Oxford University Press出版商该刊已被国际重要权威数据库SCIE收录。期刊聚焦Medicine-Rheumatology领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的...
Therapeutic Advances in Musculoskeletal Disease 影响因子:3.4 中科院大类分区:医学-2区 中科院小类分区:风湿病学-3区 年发文量:48 自引率:2.9% 审稿周期:平均18周 推荐理由:该期刊是一本风湿病学领域的SCI期刊,国际认可度非常高,但是在国内知名度较低,发文量较少。该期刊速度不算快,但审稿很认真,质量有保证,...
advances in rheumatology 期刊简称 Print ISSN 2523-3106 Online ISSN 2523-3106 期刊出版社 是否开放获取 Open Access,OA 是 官网地址 期刊所属领域 期刊简介 JCR分区索引信息2021年数据 是否是SCIE(SCI) 注:SCI已经完全被SCIE取代,参考:SCI被取代 SCIE索引 ...
影响因子是衡量期刊水平的重要指标,一般而言,影响因子较高的期刊投稿命中率较低,相对较难中,而影响因子较低的期刊则相对容易发表,为方便大家投稿时选刊,耐特译根据2020年公布的2019年期刊影响因子高低对各个学科期刊进行了排名,供大家投稿时参考。 风湿病学(RHEUMATOLOGY)领域SCIE期刊及其影响因子排名如下: Rank Full Jou...
practice. We pack each issue with original articles, case reports, reviews, brief reports, expert commentary, letters to the editor, and more. This is where you'll find the answers to tough patient management issues as well as the latest information about technological advances affecting your ...
practice. We pack each issue with original articles, case reports, reviews, brief reports, expert commentary, letters to the editor, and more. This is where you'll find the answers to tough patient management issues as well as the latest information about technological advances affecting your ...
practice. We pack each issue with original articles, case reports, reviews, brief reports, expert commentary, letters to the editor, and more. This is where you'll find the answers to tough patient management issues as well as the latest information about technological advances affecting your ...
The main criterion for consideration will be that, in addition to the clinical description of a case or cases, the report includes investigative research that advances the field of rheumatology by, e.g., providing a key insight into disease mechanism. These should be submitted in brief report ...
The main criterion for consideration will be that, in addition to the clinical description of a case or cases, the report includes investigative research that advances the field of rheumatology by, e.g., providing a key insight into disease mechanism. These should be submitted in brief report ...